Brian Bell PhD Amgen Inc.

Brian Bell is Sr. Director at Amgen leading the Cellular Sciences team within Process Development, Attribute Sciences. Cellular Sciences is responsible for adventitious agent control strategies including viral clearance study execution, mycoplasma testing for clinical programs, assay evaluation and development for bioburden, endotoxin, sterility, and viral contaminates, production, qualification, and management of critical reagents, and authoring, review, and responding to health authority inquiries on adventitious agent control and methods for regulatory documents. Brian earned a PhD in Biomedical Research from The Ohio State University studying microbial pathogenesis. Prior to working in the pharmaceutical industry, Brian researched biothreat agents for government and industrial clients.